Autosomal dominant hypoparathyroidism with severe hypomagnesemia and hypocalcemia, successfully treated with recombinant PTH and continuous subcutaneous magnesium infusion

Journal of Pediatric Endocrinology and Metabolism

Volumn 21, Issue 4, 2008, Pages 385-391

  Sanda, Srinath ^a,c   Schlingmann, Karl P ^b   Newfield, Ron S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Bartter syndrome; Calcium sensing receptor; Hypocalcemia; Hypomagnesemia; Recombinant human parathyroid hormone

Indexed keywords

ANTIBIOTIC AGENT; BICARBONATE; CALCITRIOL; CALCIUM CARBONATE; CALCIUM SENSING RECEPTOR; GLUCONATE CALCIUM; HYDROCHLOROTHIAZIDE; MAGNESIUM; MAGNESIUM OXIDE; MAGNESIUM SULFATE; PARATHYROID HORMONE[1-34]; THIAZIDE DIURETIC AGENT;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADJUVANT THERAPY; ARTICLE; AUTOSOMAL DOMINANT HYPOPARATHYROIDISM; BARTTER SYNDROME; BICARBONATE BLOOD LEVEL; CASE REPORT; CELLULITIS; CHRONIC DIARRHEA; CLINICAL FEATURE; CONTINUOUS INFUSION; DEEP VEIN THROMBOSIS; DRUG DOSE INCREASE; DRUG MEGADOSE; FAILURE TO THRIVE; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HYPOCALCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOPARATHYROIDISM; INFECTION; INSULIN PUMP; LABORATORY TEST; MUCOSAL DISEASE; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYURIA; PRESCHOOL CHILD; SALT LOSING NEPHRITIS; SEIZURE; SKIN IRRITATION;

EID: 44949105547     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2008.21.4.385     Document Type: Article

References (19)

1. Thakker RV. Diseases associated with the extracellular calcium-sensing receptor. Cell Calcium 2004; 35: 275-282.
2. Tfelt-Hansen J, Brown EM. The calcium-sensing receptor in normal physiology and pathophysiology: a review. Crit Rev Clin Lab Sci 2005; 42: 35-70.
3. Sato K, Hasegawa Y, Nakae J, Nanao K, Takahashi I, Tajima T, Shinohara N, Fujieda K. Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene. J Clin Endocrinol Metab 2002; 87: 3068-3073.
4. Mittelman SD, Hendy GN, Fefferman RA, Canaff L, Mosesova I, Cole DE, Burkett L, Geffner ME. A hypocalcemic child with a novel activating mutation of the calcium-sensing receptor gene: successful treatment with recombinant human parathyroid hormone. J Clin Endocrinol Metab 2006; 91: 2474-2479.
5. Shiohara M, Shiozawa R, Kurata K, Matsuura H, Arai F, Yasuda T, Koike K. Effect of parathyroid hormone administration in a patient with severe hypoparathyroidism caused by gain-of-function mutation of calcium-sensing receptor. Endocr J 2006; 53: 797-802.
6. Pearce SH, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P, Brown EM, Thakker RV. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 1996; 335: 1115-1122.
7. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874-879.
8. Lienhardt A, Bai M, Lagarde JP, Rigaud M, Zhang Z, Jiang Y, Kottler ML, Brown EM, Garabedian M. Activating mutations of the calcium-sensing receptor: management of hypocalcemia. J Clin Endocrinol Metab 2001; 86: 5313-5323.
9. Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, Chikatsu N, Fujita T. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 2002; 360: 692-694.
10. Vargas-Poussou R, Huang C, Hulin P, Houillier P, Jeunemaitre X, Paillard M, Planelles G, Dechaux M, Miller RT, Antignac C. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol 2002; 13: 2259-2266.
11. Vezzoli G, Arcidiacono T, Paloschi V, Terranegra A, Biasion R, Weber G, Mora S, Syren ML, Coviello D, Cusi D, Bianchi G, Soldati L. Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome. J Nephrol 2006; 19: 525-528.
12. Sanda S, Newfield R, Gottschalk M. The use of teriparatide for the treatment of hypocalcemia and hypomagnesemia in a child with congenital hypomagnesemia. 87th Annual Meeting of the Endocrine Society, San Diego, CA, 2005; Abst P2-383.
13. Konrad M, Schlingmann KP, Gudermann T. Insights into the molecular nature of magnesium homeostasis. Am J Physiol Renal Physiol 2004; 286: F599-605.
14. 2+-sensing receptor in divalent mineral ion homeostasis. J Exp Biol 1997; 200: 295-302.
15. Roberts JR. Cutaneous and subcutaneous complications of calcium infusions. JACEP 1977; 6: 16-20.
16. Goldminz D, Barnhill R, McGuire J, Stenn KS. Calcinosis cutis following extravasation of calcium chloride. Arch Dermatol 1988; 124: 922-925.
17. Bichler KH, Eipper E, Naber K, Braun V, Zimmermann R, Lahme S. Urinary infection stones. Int J Antimicrob Agents 2002; 19: 488-498.
18. Martinez-Riquelme A, Rawlings J, Morley S, Kendall J, Hosking D, Allison S. Self-administered subcutaneous fluid infusion at home in the management of fluid depletion and hypomagnesaemia in gastro-intestinal disease. Clin Nutr 2005; 24: 158-163.
19. Aries PM, Schubert M, Muller-Wieland D, Krone W. (Subcutaneous magnesium pump in a patient with combined magnesium transport defect - in German] Dtsch Med Wochenschr 2000; 125: 970-972.